Basel, Switzerland

Christian Ostermeier

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 9.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Christian Ostermeier: Innovator in Filamentous Fungal Cell Technology

Introduction

Christian Ostermeier is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of filamentous fungal cells for the production of glycoproteins. With a total of two patents to his name, Ostermeier's work focuses on enhancing the efficiency and quality of protein production.

Latest Patents

Ostermeier's latest patents include innovations that address the production of heterologous proteins with reduced O-mannosylation in filamentous fungal cells. The first patent describes a PMT-deficient filamentous fungal cell that incorporates mutations to reduce endogenous protease activity and O-mannosyltransferase activity. This advancement allows for more efficient production of glycoproteins with mammalian-like N-glycans. The second patent further elaborates on the production of recombinant glycoproteins, detailing a filamentous fungal cell that includes specific mutations and polynucleotides to enhance glycoprotein quality.

Career Highlights

Christian Ostermeier is currently associated with Glykos Finland Oy, where he continues to innovate in the field of biotechnology. His work has been instrumental in advancing the capabilities of filamentous fungi as a platform for protein production. Ostermeier's research has the potential to impact various industries, including pharmaceuticals and biotechnology.

Collaborations

Ostermeier collaborates with esteemed colleagues such as Jari Natunen and Jukka Hiltunen. Their combined expertise contributes to the ongoing research and development efforts at Glykos Finland Oy.

Conclusion

Christian Ostermeier is a pioneering inventor whose work in filamentous fungal cell technology is shaping the future of protein production. His patents reflect a commitment to innovation and excellence in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…